Pnina Fishman

Pnina Fishman

Founder at CAN-FITE BIOPHARMA LTD.

Net worth: 1 091 $ as of 2025-04-29

75 year
Health Technology
Consumer Services
Health Services

Profile

Pnina Fishman is the founder of Can-Fite BioPharma Ltd. since 1994, holding the title of Executive Chairman & Chief Scientific Officer.
Current jobs include Director at Eyefite Ltd., Director at Consulting F.D.
International Marketing & Engineering Ltd., Director at Ultratrend Ltd., and Director at Fd Consulting Ltd. Former jobs include Chief Executive Officer at Mor Research Applications Ltd., Chairman at OphthaliX, Inc. from 2013 to 2014, and Professor at Rabin Medical Center Beilinson.
Education includes a doctorate from Bar-Ilan University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-27 263,433 ( 0.01% ) 1 091 $ 2025-04-29

Pnina Fishman active positions

CompaniesPositionStart
CAN-FITE BIOPHARMA LTD. Founder 1994-09-10
Consulting F.D. International Marketing & Engingeering Ltd.
Director/Board Member -
Director/Board Member -
Ultratrend Ltd.
Director/Board Member -
Fd Consulting Ltd.
Director/Board Member -
All active positions of Pnina Fishman

Former positions of Pnina Fishman

CompaniesPositionEnd
Corporate Officer/Principal -
Mor Research Applications Ltd.
Chief Executive Officer -
Chief Executive Officer -
See the detail of Pnina Fishman's experience

Training of Pnina Fishman

Bar-Ilan University
Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pnina Fishman's experience

Connections

20

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
CAN-FITE BIOPHARMA LTD.

Health Technology

Private companies7

Health Technology

Consulting F.D. International Marketing & Engingeering Ltd.

Health Technology

Ultratrend Ltd.

Health Services

Mor Research Applications Ltd.

Fd Consulting Ltd.

See company connections
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW